NEW YORK (GenomeWeb News) - BioMachines and the University of Massachusetts Medical School announced a partnership to create a new proteomic division at the company, BioMachines said today.
The new division will be named Applied Proteomics Services. According to BioMachines CEO Tom Larrichio, the company will provide protein analysis through a fee-for-service model.
Sunny Tam and Douglas Hinerfeld, researchers from the medical school's Proteomic Fractionation Group, will support the new division.
Under the agreement, the group will provide diverse proteomic sample preparation, fractionation, and mass spectrometry services for analysis.